The therapeutic potential of ghrelin in IBD is possibly linked to the activation of the vagus nerve [77] and the transcriptional activity of peroxisome proliferator-activated receptor gamma (PPARγ) [78]. This evidence concerns the gene GHRL and inflammatory bowel disease.